Fentanyl Addiction
Fentanyl addiction can make opioid use difficult to control. Learn the signs, how overdose and withdrawal differ, and what medication and ongoing treatment can offer.
Battling addiction & ready for help?
Finding Help for Fentanyl Addiction
Fentanyl is a powerful laboratory-made opioid, a drug that relieves pain and can slow breathing. Fentanyl addiction is usually diagnosed as opioid use disorder: a pattern of opioid use that becomes difficult to control and causes harm. Treatment can help, including when someone is using fentanyl from the illegal drug supply.[1][2][3]
When Fentanyl Exposure Needs Emergency Help
If someone cannot be awakened or has slow, shallow, or difficult breathing, give naloxone if available and call 911. Follow the dispatcher’s instructions to help the person breathe. If they are breathing but unconscious, place them on their side. Stay until help arrives.[4][5]
Fast Facts About Fentanyl
These points explain the key differences in fentanyl use, risks, and treatment.
- Opioid use disorder is treatable. Methadone, buprenorphine, and naltrexone are approved medications for opioid use disorder.[1] People with opioid use disorder who are treated with methadone or buprenorphine are less likely to die or to have an overdose than those who do not receive treatment.[3]
- Pharmaceutical fentanyl is an approved prescription pain medicine, while most fentanyl contributing to the current United States overdose crisis is made illegally.[1]
- A person cannot reliably determine whether an illicit pill or drug contains fentanyl by its appearance, taste, source, or effects.[1][6]
Fentanyl Overdose Signs and Emergency Response
Treat possible opioid overdose as an emergency. If it is difficult to decide whether someone is merely intoxicated or overdosing, the Centers for Disease Control and Prevention advises responding as though it is an overdose.[2]
Signs include:
- Unconsciousness or inability to awaken.[2]
- Slow or shallow breathing.[2]
- Choking, gurgling, or snoring sounds from someone who cannot be awakened.[2]
- Difficulty breathing.[2]
- Discolored lips, nails, or skin.[2]
- Very small “pinpoint” pupils that do not react to light.[2]
Skin discoloration is only one possible sign. Also check breathing and whether the person can be awakened.[2]
What to Do for a Suspected Fentanyl Overdose
Take these steps without waiting to identify the exact drug:
- Give naloxone if available and call 911. Follow the naloxone product instructions. Do not wait to know which drug was taken.[4]
- Help the person breathe. Follow the emergency dispatcher’s instructions to support breathing. A person who is breathing but unconscious should be placed on their side to help prevent choking.[4][5]
- Give another dose if normal breathing has not returned after 2–3 minutes. Follow the product instructions and emergency dispatcher’s guidance.[4]
- Stay until emergency help arrives, even if the person wakes up. Naloxone is one step in emergency care, not a reason to cancel the ambulance.[4]
Naloxone is available over the counter without a prescription in the United States. Standard-strength naloxone works to reverse fentanyl’s effects in most people who overdose, but some people may need another dose.[1]
Most states have laws that may protect the person overdosing or the person seeking help from some criminal penalties. The scope of these laws varies, so legal protection should not be assumed to be identical everywhere.[2]
How Do Prescription Fentanyl and Illegally Made Fentanyl Differ?
The word “fentanyl” can refer to a regulated prescription medicine or to fentanyl made for the illicit market. The fentanyl molecule can be the same, but regulated dosing and medical monitoring differ from an unknown pill or powder. Evidence about supervised treatment does not establish the safety of an illicit product.[7]
Opioids are drugs with morphine-like effects. They include prescription medicines such as morphine and fentanyl, as well as heroin. Fentanyl is synthetic, meaning it is made in laboratories rather than derived from natural ingredients.[1]
Illegally Made Fentanyl
Illegally made fentanyl is produced outside regulated pharmaceutical manufacturing. It can be sold as fentanyl, added to heroin or stimulants, or pressed into counterfeit pills made to resemble prescription medicines. People may therefore use it intentionally, suspect it is present, or be exposed without knowing.[1][8]
Illicit fentanyl has also been found in combinations involving cocaine, methamphetamine, heroin, and xylazine, a veterinary tranquilizer. Combining drugs can increase the chance of serious effects or death, whether the combination was intentional or hidden from the person using it.[1]
Counterfeit pills frequently imitate oxycodone or alprazolam but may contain illegally manufactured fentanyls, illicit benzodiazepines, or other substances. Benzodiazepines are sedating medicines used for conditions such as anxiety, insomnia, and seizures. Alprazolam is one example. A pill’s markings and appearance are not proof of its ingredients.[8][9]
Pharmaceutical Fentanyl
Pharmaceutical fentanyl is a regulated prescription medicine for severe pain, including certain surgical, cancer, and chronic-pain settings. It is supplied in specific formulations and used under medical supervision. Illegally made fentanyl has uncertain contents and strength. Evidence from supervised pain care does not establish its safety.[1]
Comparing Prescription Fentanyl With Illegally Made Fentanyl
A prescription identifies a particular medicine and instructions. An illicit pill or powder does not provide that assurance. Appearance cannot confirm what a drug contains, and the presence of fentanyl may be unexpected.[1][6]
Fentanyl Use, Misuse, Dependence, and Opioid Use Disorder
Using fentanyl does not by itself establish addiction. The broader opioid use disorder diagnosis covers problems involving fentanyl and other opioids. Ordinary medical use, misuse, intoxication, physical dependence, withdrawal, and opioid use disorder describe different situations, although more than one can occur at the same time.
| Term | What It Means | What It Does Not Establish |
|---|---|---|
| Medical use | Taking prescribed fentanyl as directed for its clinical purpose.[1] | It does not by itself establish misuse or opioid use disorder. |
| Misuse | Taking a prescription pain reliever without one’s own prescription, or using it in a greater amount, more often, longer, or otherwise differently than directed.[6][9] | It is not automatically a diagnosis of opioid use disorder. |
| Intoxication | Being under a drug’s influence, sometimes described as being “high.” It may be difficult for a bystander to distinguish this from overdose.[2] | Being high is not itself a diagnosis of opioid use disorder. If overdose is possible, respond as an emergency.[9][2] |
| Physical dependence | The body has adapted its normal functioning around regular opioid use, so stopping can cause withdrawal.[1][9] | Dependence alone does not establish addiction or compulsive use.[6] |
| Tolerance | The body responds less to the same exposure, so a person may need more to obtain the same effect.[1] | Tolerance alone is not proof of opioid use disorder.[6] |
| Opioid use disorder | A diagnosable medical condition involving a problematic pattern of opioid use that causes significant impairment or distress, meaning serious disruption of life or suffering.[1][9] | Exposure alone does not establish the diagnosis, and tolerance or withdrawal during appropriate medical treatment is not sufficient.[6] |
Tolerance and withdrawal can be normal physical adaptations to appropriately supervised prescription treatment. In the 2023 national survey’s diagnostic approach, tolerance and withdrawal were not counted toward prescription-drug use disorder for people who used but did not misuse their medication.[6]
Signs of Fentanyl-Related Opioid Use Disorder
No single sign provides a diagnosis. Seek assessment when opioid use is hard to control, continues despite harmful effects, causes social problems, or interferes with responsibilities at work, school, or home. These are reasons for a clinical conversation, not a self-test that confirms a disorder.[1][9]
Clinicians look for at least two applicable symptoms within a 12-month period. These can include taking more than intended, repeated unsuccessful efforts to cut down, cravings, giving up activities, or continuing despite harm. Tolerance and withdrawal do not count toward the diagnosis when opioids are taken solely under appropriate medical supervision.[10]
For example, repeatedly using more fentanyl than planned and missing work because of use are reasons to ask for an assessment. Needing a prescribed medicine to prevent withdrawal is a different question. You do not have to decide which label fits before asking for help.[10]
A practical reason to seek assessment is not only to assign a label. It is to discuss whether the signs meet opioid use disorder criteria and to consider overdose risk, withdrawal concerns, and treatment options.[9][1]
Short-Term Fentanyl Effects and Overdose Risk
Fentanyl can relieve severe pain, but excessive opioid effect can suppress breathing. In the illicit market, uncertain contents make it harder to judge how much opioid exposure a product may produce.[1]
Fentanyl can also cause drowsiness, confusion, nausea and constipation. Being unusually sleepy does not prove addiction, but being unable to wake up or breathing abnormally requires an overdose response.[1][4]
Why Combining Fentanyl With Other Drugs Raises Risk
Using fentanyl with other substances can produce more serious effects. This includes combinations encountered intentionally and fentanyl hidden in a drug that a person believed was heroin, cocaine, methamphetamine, or a prescription pill.[1]
Counterfeit pills may contain illegally made fentanyl, illicit benzodiazepines, or other drugs. Appearance cannot establish their contents. Separately, CDC guidance warns that combining benzodiazepines with opioids increases overdose and death risk. This interaction matters whether the medicines were prescribed or obtained illicitly.[8][1][9]
Overdose deaths increasingly involve more than one drug, and death categories overlap when several substances contributed. Finding multiple drugs does not, by itself, reveal which substance was taken knowingly or which one played the largest role.[1][11]
Fentanyl Mixed With Xylazine
Xylazine is an animal sedative that has been found mixed with fentanyl. It is not an opioid. Give naloxone for a suspected overdose even when xylazine may be involved, because naloxone can reverse an opioid’s effects. It will not reverse xylazine itself. Call 911, help with breathing as directed and stay with the person.[5]
Xylazine exposure can also involve serious skin wounds. Seek care for wounds before they worsen. Learn more about xylazine and fentanyl mixtures.[5]
Routes of Use Do Not Remove Overdose Risk
Injection has additional infection risks, but avoiding injection does not eliminate overdose risk. In the counterfeit-pill surveillance, smoking was more than twice as frequent among deaths with counterfeit-pill evidence as among deaths without it, and over half of such deaths in western jurisdictions had evidence of smoking.[8] Rapid absorption can make smoking an overdose risk as well.[8]
That observation is not a calculation of the overdose probability for smoking versus injection. It shows that prevention and naloxone access must include people who smoke or swallow drugs, not only people who inject them.
Counterfeit Pills and Unexpected Fentanyl Exposure
Treat pills from the illicit market as having uncertain contents. Counterfeit pills may closely resemble legitimate oxycodone or alprazolam products while containing illegally made fentanyl, illicit benzodiazepines, or other drugs.[8]
A familiar appearance or supplier does not establish what is in a pill. The 2023 national survey report notes that appearance, taste, and purchase from a known source are unreliable indicators of illegally made fentanyl.[6] Even physical effects are not completely reliable.[6]
Why a Pill That Looks Prescribed May Contain Fentanyl
A pill obtained from the illicit market has the color and marking of a prescription pain medicine. Its appearance cannot confirm its ingredients. Treating it as an uncertain product, keeping naloxone nearby, avoiding solitary use, and considering drug checking address the risk without pretending that any one measure guarantees safety.[8][1]
Fentanyl Test Strips and Their Limits
Fentanyl test strips are small paper drug-checking tools. A sample is mixed with water and the strip is used and interpreted according to its instructions. They can provide information about whether fentanyl is detected in that sample, but they cannot certify that an entire pill, bag, or batch is safe.[1]
A negative result can be wrong if the tested sample did not contain the fentanyl present elsewhere in the product. Some fentanyl-related substances may also escape detection. A negative strip therefore does not guarantee the absence of fentanyl or its analogues, which are chemically related substances.[1][12]
What Fentanyl Test Strips Can Tell You
Test strips can supply information that appearance and taste cannot. CDC guidance on counterfeit pills supports access to strips and broader drug-checking services alongside naloxone and avoiding use while alone.[8]
In interviews with 20 people reporting opioid use in the previous 30 days in Baltimore, participants described fentanyl as pervasive and the local supply as difficult to predict.[13] Some used strips not only to avoid fentanyl but also to discuss products with suppliers and share information within social networks.[13]
This small qualitative study explains how people used the strips in one fentanyl-saturated market. It does not estimate how well test strips prevent overdose or represent everyone who uses drugs.
What Fentanyl Test Strips Cannot Tell You
Test strips do not measure fentanyl quantity or purity, rule out other dangerous drugs, or show that a small sample represents the whole product. A negative result does not guarantee safety. False-negative results and confusion about how to interpret results are possible.[12][14]
Ask the service supplying the strips to explain the instructions and what the results mean. Keep naloxone available and use other overdose-prevention measures whether the result is positive or negative. Test strips should not be the only protection.[1][12]
Practical Ways to Reduce Fentanyl Risk
No step makes an uncertain drug product risk-free. Layering protections is more useful than relying on appearance, a single test, or confidence in a supplier.
Useful measures supported by the evidence include:
- Carry naloxone and make sure others know where it is. Anyone can carry and administer it during a suspected opioid overdose.[2]
- Avoid using drugs alone. CDC counterfeit-pill guidance specifically pairs drug checking with naloxone availability and not using alone.[8]
- Treat pills from the illicit market as uncertain. Counterfeit products can imitate legitimate medicines.[8]
- Use test strips before consumption when available. Follow local instructions and remember that a negative result is not a guarantee.[12]
- Do not limit precautions to opioids or injection. Fentanyl can occur in stimulants, and overdose deaths involving counterfeit pills also occur after smoking or ingestion.[1][8]
- Seek assessment after an overdose or repeated near-overdose. Emergency care can become an entry point for opioid use disorder treatment, including buprenorphine.[15]
Risk-reduction conversations should be practical rather than punitive. A person may not be ready to stop, may intentionally seek fentanyl, or may have limited access to private space, transportation, healthcare, and drug-checking supplies. The Wisconsin study found that these logistical and social factors affected test-strip use.[12]
What Are the Longer-Term Health Risks of Fentanyl Use?
Repeated fentanyl exposure can lead to tolerance, physical dependence, and opioid use disorder. It can also place people at repeated risk of overdose when product strength or composition changes.[1]
Long-term health evidence must be interpreted carefully because many studies group fentanyl with other opioids or examine people using several drugs. An observed health problem in a population with opioid or stimulant diagnoses is not necessarily a fentanyl-specific effect.
Physical Dependence and Tolerance
With repeated opioid exposure, the body can adapt. Tolerance means the same exposure produces less effect. Physical dependence means a reduction or stop can trigger withdrawal. Both can occur during prescribed treatment as well as nonmedical use.[1][6]
Dependence becomes especially relevant when access changes, a product is unexpectedly weaker, or a person tries to stop. It also affects treatment planning because withdrawal discomfort can make continued opioid use more likely.
If you are stopping or reducing opioid use, ask a clinician how physical dependence and withdrawal will be addressed. With prescribed opioids, CDC guidance recommends assessment for misuse or opioid use disorder when prescriptions change, with connection to evidence-based treatment when needed.[1][8]
Infection Risks and Getting Care
Injection can expose a person to serious infections. Ask a healthcare or harm-reduction service about sterile supplies, wound care, and testing for HIV and hepatitis. A suspected infection needs assessment. Its appearance cannot identify which drug someone used.[16][5]
Mental Health and Co-Occurring Substance Use
Mental health and substance use often overlap, but population associations do not establish which came first or whether one caused the other.
Discuss mental health concerns and co-occurring substance use (use of other substances alongside opioids) during assessment, without presuming that fentanyl explains every symptom. Population associations support considering these concerns together but do not establish a fentanyl-specific cause.[6]
Fentanyl Withdrawal and Changes in Use
Withdrawal can occur when a person who is physically dependent on opioids stops or substantially reduces exposure. It can be extremely unpleasant, but withdrawal management is only one part of care.[1]
Physical dependence means the body has adjusted to regular opioid use. It is this adaptation that explains withdrawal when use stops. Simply knowing that someone took an opioid does not establish dependence.[9]
What Symptoms Can Opioid Withdrawal Cause?
Opioid withdrawal can involve anxiety, restlessness, aching muscles, sweating, a runny nose, yawning, and difficulty sleeping. Abdominal cramps, nausea, vomiting, diarrhea, and goosebumps can also occur. These symptoms describe opioid withdrawal generally. They do not establish a fixed fentanyl withdrawal timeline for every person.[16]
How Is Opioid Withdrawal Managed?
Medical detox and withdrawal care aim to address the immediate symptoms that follow reduction or cessation. Lofexidine is approved to treat opioid withdrawal symptoms. It is not the same as an ongoing medication for opioid use disorder.[1]
A personal taper (a planned reduction in medication), waiting period or medication schedule requires an individual clinical discussion. Ask how the plan will address withdrawal and whether you also need ongoing treatment for opioid use disorder. Detox alone is not recommended treatment for opioid use disorder, because return to use and overdose remain risks.[17]
Vomiting and diarrhea can cause dehydration, and tolerance falls after stopping opioids. A dose that someone previously used can cause an overdose after a break. Contact a healthcare professional about withdrawal and an ongoing treatment plan.[16]
Withdrawal care without continuing treatment may leave the underlying opioid use disorder untreated. A plan should therefore distinguish getting through withdrawal from reducing longer-term overdose risk and supporting recovery.
Why Ongoing Treatment Matters After Opioid Withdrawal
Ongoing treatment addresses opioid use disorder over time and can support recovery through medication and behavioral therapy. It is distinct from medication used only to manage withdrawal symptoms or reverse an overdose.[1][3]
Emergency care can be an entry point for buprenorphine treatment. A systematic review found that starting it in emergency departments or emergency medical services was associated with greater early treatment engagement, but initiation was only one component of a longer care pathway. Ask where continuing care will take place after the first encounter.[15]
How Is Fentanyl-Related Opioid Use Disorder Treated?
Opioid use disorder is treatable. People with opioid use disorder who are treated with methadone or buprenorphine are less likely to die or to have an overdose than those who do not receive treatment.[3]
The medications approved in the United States are methadone, buprenorphine, and naltrexone. Behavioral therapy may be added, but medication is a standard part of treatment.[1]
The evidence base is for opioid use disorder, not a separate diagnosis called “fentanyl addiction.” Fentanyl exposure can be the opioid pattern underlying the disorder, but studies may include people using heroin, prescription opioids, fentanyl, or combinations.
Medications Used for Opioid Use Disorder and Withdrawal
The options differ in purpose and how treatment is delivered. Use this comparison to prepare questions about medication and follow-up, not to select a personal starting schedule.
| Medication | What It Does In Treatment | Important Practical Considerations |
|---|---|---|
| Methadone | An opioid medication that activates opioid receptors, the sites where opioids act in the nervous system, to ease withdrawal symptoms and cravings during ongoing treatment.[18] | For ongoing opioid use disorder care in the United States, methadone is generally provided through a certified opioid treatment program. Ask about assessment, required visits, transportation and take-home arrangements.[17] |
| Buprenorphine | A medication that partially activates opioid receptors to ease withdrawal symptoms and cravings. Some products combine it with naloxone.[18][3] | Forms include medicine dissolved in the mouth and long-acting injections. Office-based clinicians and some emergency departments provide care. Ask when and how to start and who will manage follow-up.[3][17] |
| Naltrexone | A nonaddictive medication that blocks opioids from attaching to opioid receptors and producing their effects.[18][1] | An opioid-free interval is needed before starting, to avoid sudden severe withdrawal. After repeated fentanyl use, this can be difficult and requires an individual medical plan. Ask whether naltrexone fits your situation and how care will be provided before the first dose.[17][19] |
| Lofexidine | A medication approved for opioid withdrawal symptoms.[1] | It addresses withdrawal symptoms rather than serving as ongoing medication treatment for opioid use disorder.[3] |
Methadone and buprenorphine do not produce the same intense pleasurable effects as illicit opioids when appropriately prescribed to a person with opioid use disorder. Naltrexone is not addictive. These facts do not mean that every medication suits every person or that monitoring is unnecessary.[1]
Starting Treatment After Fentanyl Use
Buprenorphine can trigger a sudden worsening of withdrawal if it displaces other opioids before the person is ready for the chosen starting approach. This is called precipitated withdrawal. It is a reason to plan treatment carefully, not to conclude that medication cannot help.[19]
The American Society of Addiction Medicine’s 2023 expert considerations recommend individualizing buprenorphine initiation after exposure to potent synthetic opioids. Clinicians may consider different starting approaches or a different medication when a previous attempt has not worked. These are expert recommendations informed by developing evidence, not one schedule that works for everyone.[19]
Tell the clinician about recent fentanyl use, other medicines or drugs, and any previous severe withdrawal after buprenorphine. Ask: “What symptoms should I expect, who can I contact, and what is the plan if I feel worse?” A drug-test detection window or a fixed number of hours from the internet cannot choose your starting plan.[19]
How Methadone and Buprenorphine Compare
A population-based cohort study used health administrative data from British Columbia, Canada. It included adults starting buprenorphine with naloxone or methadone between January 1, 2010, and March 17, 2020, while excluding people who were incarcerated, pregnant, or receiving palliative cancer care at treatment initiation.[20]
Among 30,891 first-time treatment recipients, 88.8% starting buprenorphine with naloxone and 81.5% starting methadone met the study’s definition of discontinuation within 24 months.[20] Discontinuation meant a treatment gap of at least six days for buprenorphine/naloxone or five days for methadone. In an analysis approximating treatment according to dosing guidance, the corresponding figures were 42.1% and 30.7%.[20]
In practical terms, methadone was associated with better treatment continuation in this Canadian population. The study did not randomly assign medication, so personal characteristics and care circumstances may have influenced both selection and continuation.
Mortality while receiving treatment was low, and the estimates did not demonstrate that one medication was superior. Among first-time recipients in the analysis approximating treatment as intended, mortality was 0.08% with buprenorphine and 0.13% with methadone at 24 months, but the interval around the comparison was wide.[20]
The study reported similar patterns after fentanyl entered the market and across examined subgroups. That supports relevance to a changing opioid supply, but it remains evidence from British Columbia’s healthcare system rather than a universal rule for United States care.[20]
Starting Buprenorphine in Emergency Care
A systematic review assessed buprenorphine initiation in emergency departments and emergency medical services. In randomized studies with 227 participants, initiation in these settings was associated with almost six times the odds of treatment engagement at 30 days.[15] In observational studies with 779 participants, it was associated with more than four times the odds.[15]
These odds comparisons indicate greater early engagement. They do not mean that six or four times as many patients stayed in care. Across studies and measured time points, treatment retention ranged from 77% within 24 hours to 35% at 12 months.[15] Those figures are not necessarily a single group’s trajectory, but they reinforce the importance of continuing care after initiation.[15]
Among 851 participants, the pooled reported rate of precipitated withdrawal was 0%, with an interval extending to 1%.[15] Precipitated withdrawal is a sudden onset or worsening of withdrawal after medication initiation. A low reported rate does not mean it is impossible or that everyone should follow the same initiation procedure.[15]
Patients and clinicians were generally supportive of emergency-department initiation. Patients valued shared decision-making, while clinicians noted that a busy emergency environment could make those conversations difficult. The reviewers described initiation as one component of a longer care pathway.[15]
Medication Access Is Part of the Treatment Decision
In a 2024 NIDA commentary, Nora Volkow, M.D., wrote that “highly effective medications like buprenorphine and methadone remain underused.” She described transportation, distance from treatment programs and stigma as barriers, particularly for people seeking methadone.[21]
The practical question is whether the plan can work in your life. Before choosing a service, ask about medication availability, visit frequency, transport, cost, pharmacy access and follow-up. Tell the team if work or childcare makes repeated visits difficult. Those details belong in planning care, alongside symptoms and treatment preferences.
Counseling and Continuing Support
Counseling can help with coping skills, relationships and other mental health needs. Medication should not be withheld or delayed just because counseling is unavailable or someone declines it. Discuss what support would be useful rather than assuming everyone needs the same program.[17]
Fentanyl rehab can involve outpatient visits or a more intensive setting. Ask what medical care and ongoing medication a program actually provides, including what happens after discharge. “Rehab” is not a guarantee that every medication option is offered.
What the Broader Opioid Treatment Evidence Shows
No medication is best for every person. Ask a clinician which options the service offers, how follow-up works, and how the plan will change if it is not helping. Your preferences and practical barriers belong in the decision alongside the clinical evidence.[20][15]
Pregnancy and Fentanyl Use
Do not abruptly stop opioids during pregnancy on your own. Contact a prenatal clinician or an opioid-treatment provider for a treatment plan. Methadone and buprenorphine are recommended first-line medications for opioid use disorder during pregnancy. Care should coordinate addiction treatment and prenatal services.[22]
A baby can develop withdrawal after exposure to opioids, including treatment medication. That possibility alone is not a reason to withhold treatment. The pediatric team can monitor and treat the baby. Ask who will coordinate care during pregnancy, after delivery, and through the postpartum period.[22]
How Can People and Families Find Help for Fentanyl Use?
Helpful action depends on immediate risk, readiness, and access. A person does not have to commit to lifelong abstinence before receiving naloxone, drug-checking information, respectful medical care, or an assessment.
Supporting Someone Who Is Not Ready to Stop Fentanyl Use
Keep the focus on survival and connection. Offer naloxone, discuss not using alone, treat pills from the illicit market as uncertain, and make test-strip limitations clear. Avoid assuming that a positive strip will make someone discard the product.[8][12]
Ask what change feels possible. That might be carrying naloxone, testing before use, telling someone where they are, avoiding an unknown counterfeit pill, or speaking with a clinician without agreeing to treatment that day.
Finding Treatment for Fentanyl-Related Opioid Use Disorder
A manageable first request is an opioid use disorder assessment and a discussion of methadone, buprenorphine, and naltrexone. You can also explore the treatment center directory to identify services to contact. Ask how the program handles follow-up, medication continuity, other substance use, mental health concerns, pain, and overdose prevention.
In the United States, the Substance Abuse and Mental Health Services Administration’s National Helpline is 1-800-662-HELP (4357), and FindTreatment.gov can be used to search for substance-use and mental-health treatment providers in your area.[1] When contacting a service, ask about cost, eligibility, and when an appointment would be possible.[1]
Continuing Care After a Fentanyl Overdose
An overdose is a reason for urgent emergency response and a prompt follow-up plan. Emergency-department buprenorphine initiation is associated with improved engagement at 30 days, but a first dose or referral is not the whole treatment pathway.[15]
Before leaving care, useful questions include how naloxone will be obtained, where medication follow-up will occur, what to do if withdrawal or cravings return, and how other medical or mental health needs will be addressed.
Helping a Family Member Who Uses Fentanyl
Learn the overdose signs and how to use naloxone. Keep naloxone where others can find it quickly and know how to use it.[4] A family member can encourage care, offer transportation or practical help when possible, and set personal boundaries without presenting punishment as treatment.
If the person is in emotional crisis or at risk of suicide, call or text 988 in the United States.[1][2] If the person cannot be awakened or is not breathing normally, call 911 and use naloxone rather than calling a counseling line first.[1][2]
What Do U.S. Fentanyl Use and Overdose Statistics Show?
Population figures must be read according to what was measured. A survey estimate of opioid misuse is not automatically a fentanyl-use estimate, and a death category that includes several synthetic opioids is not a fentanyl-only count.
Why Opioid Misuse Surveys Do Not Measure All Fentanyl Use
The 2023 National Survey on Drug Use and Health is nationally representative of the United States civilian, noninstitutionalized population age 12 or older.[6] It covers substance use, substance use disorders, treatment, and mental health, but it does not represent institutionalized populations.[6]
Its commonly reported “opioid misuse” measure combines heroin use with misuse of prescription pain relievers. It excludes illegally made fentanyl, although separate detailed analyses may use broader definitions. Prescription pain relievers can also occasionally include a nonopioid that respondents identified as a pain reliever.[6]
For that reason, the standard opioid-misuse estimate should not be presented as the number of people using fentanyl. Unexpected fentanyl exposure creates an additional measurement problem because people may not know what a product contained.[6]
The survey defines prescription misuse to include using medication without one’s own prescription or using it more often or at a higher amount than prescribed. A person can therefore be classified as misusing a pain reliever even if the stated purpose was pain relief.[6]
How Many People Report Using Illegally Made Fentanyl?
The 2025 National Survey on Drug Use and Health estimated that 768,000 people aged 12 or older reported using illegally made fentanyl in the past year, 0.3% of the U.S. civilian, noninstitutionalized population in that age range.[23][24] This is an estimate of reported use, not of opioid use disorder.[23][24]
A use estimate cannot tell us how many people have fentanyl-related opioid use disorder. Diagnosis requires a problematic pattern and applicable symptoms, rather than exposure alone. The survey’s measures must be read with their specific definitions, not treated as interchangeable counts.[10][23]
Physical dependence also needs separate interpretation. Tolerance and withdrawal can occur during appropriate medical treatment. In the 2023 survey’s diagnostic approach, those two criteria were not counted toward prescription-drug use disorder among respondents who used their medication without misusing it.[6]
Why Synthetic Opioid Death Counts Are Not Fentanyl-Only Counts
Final national data for 2023 recorded 105,007 drug overdose deaths in the United States, including 79,358 involving any opioid.[25] Within the total, 72,776 deaths involved synthetic opioids other than methadone, primarily illegally manufactured fentanyl.[25] These are annual death counts, not rates among people who use fentanyl, and the synthetic-opioid figure is not a fentanyl-only count.[25]
The synthetic-opioid count declined from 73,838 in 2022 to 72,776 in 2023, then to 47,735 in final 2024 data.[25][26] The 2024 all-drug overdose total was 79,384, including 54,045 deaths involving any opioid.[26]
“Synthetic opioids other than methadone” includes fentanyl, fentanyl analogs, and tramadol. It is not a fentanyl-only count. Drug categories overlap when a death involves multiple drugs, so they cannot simply be added. Lower national counts do not establish an individual’s overdose risk or mean an illicit product is safe.[26]
The Centers for Disease Control and Prevention’s provisional mortality dashboard provides estimates for reporting periods whose final records are not yet complete. National provisional counts cover deaths occurring in the 50 states and District of Columbia, are updated as records arrive, and may initially underestimate deaths because investigations take time.[11] Provisional figures must be identified by their reporting period and distinguished from final annual counts.[11]
The dashboard category “synthetic opioids other than methadone” includes substances such as fentanyl and tramadol. It is not a fentanyl-only category. A death can also appear in more than one drug category when multiple drugs were involved, so categories should not be added together as if each represented a different person.[11]
Drug-specific reporting varies among jurisdictions. The CDC warns against comparing selected jurisdictions when their reporting completeness and identification of particular drugs differ. Provisional declines can reflect incomplete reporting, a real decline, or both. Final data are needed to distinguish these possibilities.[11]
What Overdose Data Show About Counterfeit Pills
In 30 jurisdictions with complete data, the percentage of unintentional or undetermined overdose deaths with evidence of counterfeit-pill use more than doubled from July–September 2019 to October–December 2021.[8] It tripled in western states included in the analysis.[8]
This finding demonstrates a change among recorded overdose deaths in participating jurisdictions. It is not a national estimate of how many people used counterfeit pills, and it does not show the risk attached to every individual pill.
Investigators identified counterfeit-pill evidence using death certificates, toxicology reports, medical examiner or coroner reports, and narrative descriptions. The surveillance covered 30 jurisdictions for trends and 35 with complete 2021 data for comparisons of circumstances and demographics.[8]
Among these deaths, people with evidence of counterfeit-pill use were younger and more often Hispanic or Latino than those without such evidence. These are descriptive comparisons, not proof that age or ethnicity caused the deaths. Regional patterns, access to services, and the populations represented can affect such findings.[8]
Explore Specific Fentanyl Questions
Different questions need different detail. These related topics can help you prepare for a conversation or understand a specific risk:
- Fentanyl overdose explains warning signs and emergency response. Use 911 for a suspected overdose.
- Fentanyl withdrawal symptoms describes symptoms to discuss with a clinician. Timelines vary and do not determine when to start medication.
- Fentanyl detox explains withdrawal care and its connection to continued treatment.
- Fentanyl rehab covers treatment settings and questions to ask a program.
- How long fentanyl stays in the body discusses testing and detection. A detection estimate is not a guarantee of safety or a medication-starting instruction.
- Rainbow fentanyl addresses questions about colorful illicit products. Color cannot establish a pill’s contents.
- Xylazine explains concerns about a non-opioid sedative found with fentanyl.
- Fentanyl statistics explores dated population findings. Check the year, population and drug category attached to each figure.
- The fentanyl awareness quiz is an educational activity, not a test for addiction or overdose.
The Fentanyl Facts and Myths podcast episode offers a discussion format. For immediate decisions, use the emergency response and current treatment guidance above.
Your Next Step for Fentanyl Safety or Treatment
Choose the next step that matches the situation now:
- For an overdose: Give naloxone if available and call 911. Follow the dispatcher’s instructions to help the person breathe. If they are breathing but unconscious, place them on their side. Stay until help arrives.[4][5]
- For ongoing exposure without readiness to stop: Obtain naloxone, avoid solitary use, consider test strips, and remember that no negative result guarantees safety.[8][12]
- For concern about dependence or loss of control: Ask a clinician or treatment program about an opioid use disorder assessment. Diagnosis is based on specific criteria.[9]
- For interest in treatment: Ask specifically about methadone, buprenorphine, and naltrexone, including how follow-up works and what fits the person’s circumstances.[1]
- After emergency care: Seek a continuing treatment connection. Starting buprenorphine for opioid use disorder in emergency departments or emergency medical services is associated with better early treatment engagement, but it is one part of an ongoing care path.[15]
- For treatment referrals in the United States: Call 1-800-662-HELP (4357) or search FindTreatment.gov.[1]
- For emotional crisis or suicide risk: Call or text 988. Use 911 when an overdose is suspected.[1][2]
A manageable useful step may be carrying naloxone, asking one treatment program about medication options, or learning the overdose signs.
When you are ready to discuss treatment, explore AddictionHelp’s Treatment Center Directory and ask specifically about opioid use disorder care, medication options, and follow-up.
For emotional support alongside your care, you can also explore online therapy options. Ask how counseling would fit with your medical care.
Frequently Asked Questions About Fentanyl
Can Casual Skin Contact With Fentanyl Cause The Same Emergency As Taking It?
Brief skin contact with illicit fentanyl is not expected to cause toxic effects when visible contamination is promptly removed, according to CDC/NIOSH guidance for healthcare personnel. Liquid exposure or powder left against the skin for a prolonged period poses a different risk.[27]
Overdose response should be guided by the person’s condition, especially inability to awaken and slow, shallow, or difficult breathing. CDC bystander guidance directs people to give naloxone and call 911 when overdose is suspected; it does not use mere proximity or suspected casual contact as an overdose sign.[2]
Do not let fear of being near fentanyl delay lifesaving help. If someone is unresponsive or breathing abnormally, give naloxone if available and call 911. Follow the dispatcher’s instructions to help them breathe. If they are breathing but unconscious, place them on their side. Stay until help arrives.[4][5]
Does A Negative Fentanyl Test Strip Mean A Drug Is Safe?
Is Smoking A Drug Safe From Fentanyl Overdose?
No route removes overdose risk. Smoking can produce rapid drug absorption, and counterfeit-pill surveillance documented many deaths with evidence of smoking, including more than half of counterfeit-pill deaths in the western jurisdictions studied.[8]
Is Physical Dependence The Same As Opioid Use Disorder?
Does Naloxone Work On Fentanyl?
How Can I Start Treatment for Fentanyl Addiction?
Ask a healthcare professional or treatment service for an opioid use disorder assessment and medication discussion. Buprenorphine can be provided in office-based care, while ongoing methadone treatment usually involves a certified opioid treatment program. Ask about the first appointment, medication access, cost and follow-up. Call 1-800-662-HELP (4357) for US treatment referrals.[17][1]
Can Buprenorphine Help After Fentanyl Use?
Yes. Buprenorphine is an evidence-based opioid use disorder treatment, including for people exposed to fentanyl. Starting requires an individual plan because precipitated withdrawal, a sudden worsening of symptoms after the first dose, can occur. Tell the clinician about recent use and previous experiences. Different starting approaches or methadone may be considered when a plan has not worked.[19][17]
Get Treatment Help
If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.
Exclusive offer: 20% Off BetterHelp*Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.
- Fact-Checked
- Editor
